The Effects of Health Education in Cardiovascular Diseases Prevention and Treatment

Cardiovascular Diseases Clinical Trial

Official title:

The Effects of Health Education Given by Nurse on Out-patient Compliance in Cardiovascular Diseases Prevention and Treatment in China

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01426282
• Other study ID #: JHH 001
• Status: Completed
• Phase: N/A
• First received: August 2, 2011
• Last updated: August 29, 2011
• Start date: February 2009
• Est. completion date: June 2010

Study information

• Verified date: August 2011
• Source: Harbin Medical University
• Contact: n/a
• Is FDA regulated: No
• Health authority: China:China: Ministry of Health
• Study type: Interventional

Clinical Trial Summary

The purpose of this study is to evaluate the effects of health education given by nurse on out-patient compliance in cardiovascular diseases prevention and treatment.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 5
• Est. completion date: June 2010
• Est. primary completion date: June 2010
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 30 Years to 74 Years

Eligibility

Inclusion Criteria:

• first diagnosis cardiovascular disease

Exclusion Criteria:

• Severe liver and kidney disease or cancer

• Limb movement disorder

• Cognitive impairment

• History of malignant arrhythmia or severe heart failure patients have a high risk of sudden death

• Diabetes

• Cerebrovascular disease

• History of atherosclerotic disease hospital

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label

Related Conditions & MeSH terms

• Cardiovascular Diseases

Intervention

Other:
• no intervention
no intervention
• health education
15 minutes health education given by nurse according to " The Chinese Resident Meals Guide " , "National Revision Committee of the Guidelines of Hypertension Prevention and Control in 2005" , " Guidelines on Prevention and Treatment of Blood Lipid Abnormality in Chinese Adults " , " Guideline for diagnosis and treatment of patients with chronic stable angina "," Guideline for prevention and treatment overweight and obesity in chinese adults "

Locations

Country	Name	City	State
China	the first college of Harbin Medical University	Harbin	Heilongjiang

Sponsors (1)

Lead Sponsor	Collaborator
Lihua Xu

Country where clinical trial is conducted

China, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	blood pressure	SBP and DBP	1 year	Yes
Primary	lipid	TC,LDL,TG	1 year	Yes
Primary	Adherence drug administration	Adherence drug administration in one month and in one year	1 year	Yes
Primary	Hospitalization	hospitalization due to cardiovascular and cerebrovascular disease	1 year	Yes
Secondary	Exercise time(hours/week)		1 year	Yes
Secondary	smoking	Number of smoker and Amount of smoke per day	1 year	Yes
Secondary	body weight		1 year	Yes